Retrieved April 14, 2024, from https://hstalks.com/bs/1914/.
Introduction -- Early endoscopy (1) -- Early endoscopy (2) -- Endoscopic therapy -- Adding a second therapy to epinephrine injection -- Mono or combined therapy? -- Mono or combined therapy? Risk of rebleeding -- Mono or combined therapy? Mortality -- Adding a sclerosant to epinephrine does not help -- Clips or Thermal? -- Clips or Thermal? Initial hemostasis -- Clips or Thermal? Rebleeding -- Choosing Clips or Thermal -- Clots: remove or leave it? -- EndoTx with iv PPI vs. iv PPI alone -- Clots: remove or leave it? Beneficial patients -- Clots: remove or leave it? Meta analysis (1) -- Clots: remove or leave it? Meta analysis (2) -- PPI before endoscopy? -- Pre emptive PPI (1) -- Pre emptive PPI (2) -- Adjuvant IV PPI? -- IV PPI cochrane review -- PUB Study: IV nexium vs. placebo -- Stigmata of haemorrhage -- Significantly less rebleeding -- Rebleeding within 30 days (ITT population) -- Mortality and surgery within 30 days -- Benefit irrespective of endoscopic Rx -- Benefit more Hp positive patients -- Second look endoscopy reduces rebleeding? -- Second look and selective retreatment -- Second look endoscopy -- Endoscopic retreatment vs. surgery (1) -- Endoscopic retreatment vs. surgery (2) -- Outcomes: endoscopic re-treatment and surgery -- What causes mortality? -- Proportion of non bleeding related deaths -- Non-bleeding related mortality (in-hospital death) -- Bleeding related mortality (in-hospital death) -- Should we stop aspirin? -- More recurrent bleeding with aspirin -- Yet, higher all-cause mortality without aspirin -- What have we learned? (1) -- What have we learned? (2)